Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy

被引:110
作者
Erdmann, J
Raible, J
Maki-Abadi, J
Hummel, M
Hammann, J
Wollnik, B
Frantz, E
Fleck, E
Hetzer, R
Regitz-Zagrosek, V
机构
[1] Humboldt Univ, Campus Virchow Klinikum, Charite, Dept Internal Med, D-13353 Berlin, Germany
[2] Humboldt Univ, Campus Virchow Klinikum, Charite, Dept Cardiol, D-13353 Berlin, Germany
[3] Deutesch Herzzentrum, Berlin, Germany
[4] Univ Istanbul, Inst Child Hlth, Dept Med Genet, Istanbul, Turkey
关键词
D O I
10.1016/S0735-1097(01)01387-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We studied the clinical and genetic features of hypertrophic cardiomyopathy (HCM) caused by mutations in the myosin-binding protein C gene (MYBPC3) in 110 consecutive, unrelated patients and family members of European descent. Background Mutations in the MYBPC3 gene represent the cause of HCM in similar to 15% of familial cases. MYBPC3 mutations were reported to include mainly nonsense versus missense mutations and to be characterized by a delayed onset and benign clinical course of the disease in Japanese and French families. We investigated the features that characterize MYBPC3 variants in a large, unrelated cohort of consecutive patients. Methods The MYBPC3 gene was screened by single-strand conformational polymorphism analysis and sequencing. The clinical phenotypes were analyzed using rest and 24-h electrocardiography, electrophysiology, two-dimensional and Doppler echocardiography and angiography. Results We identified 13 mutations in the: MYBPC3 gene: one nonsense, four missense and three splicing mutations and five small deletions and insertions. Of these, 11 were novel, and two were probably founder mutations. Patients with MYBPC3 mutations presented a broad range of phenotypes. In general the 16 carriers of protein truncations had a tendency toward earlier disease manifestations (33 +/- 13 vs. 48 +/-9 years; p = 0.06) and more frequently needed invasive procedures (septal ablation or cardioverter-defibrillator implantation) compared with the 9 carriers of missense mutations or in-frame deletions (12/16 vs. 1/9 patients; p < 0.01). Conclusions Multiple mutations, which include missense, nonsense and splicing mutations, as well as small deletions and insertions, occur in the MYBPC3 gene. Protein truncation mutations seem to cause a more severe disease phenotype than missense mutations or in-frame deletions. (J Am Coll Cardiol 2001;38:322-30) (C) 2001 by the American College of Cardiology.
引用
收藏
页码:322 / 330
页数:9
相关论文
共 31 条
[1]   PROGNOSTIC IMPLICATIONS OF NOVEL BETA-CARDIAC MYOSIN HEAVY-CHAIN GENE-MUTATIONS THAT CAUSE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
ANAN, R ;
GREVE, G ;
THIERFELDER, L ;
WATKINS, H ;
MCKENNA, WJ ;
SOLOMON, S ;
VECCHIO, C ;
SHONO, H ;
NAKAO, S ;
TANAKA, H ;
MARES, A ;
TOWBIN, JA ;
SPIRITO, P ;
ROBERTS, R ;
SEIDMAN, JG ;
SEIDMAN, CE .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) :280-285
[2]   CARDIAC MYOSIN BINDING PROTEIN-C GENE SPLICE ACCEPTOR SITE MUTATION IS ASSOCIATED WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY [J].
BONNE, G ;
CARRIER, L ;
BERCOVICI, J ;
CRUAUD, C ;
RICHARD, P ;
HAINQUE, B ;
GAUTEL, M ;
LABEIT, S ;
JAMES, M ;
BECKMANN, J ;
WEISSENBACH, J ;
VOSBERG, HP ;
FISZMAN, M ;
KOMAJDA, M ;
SCHWARTZ, K .
NATURE GENETICS, 1995, 11 (04) :438-440
[3]   Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy [J].
Carrier, L ;
Bonne, G ;
Bahrend, E ;
Yu, B ;
Richard, P ;
Niel, F ;
Hainque, B ;
Cruaud, C ;
Gary, F ;
Labeit, S ;
Bouhour, JB ;
Dubourg, O ;
Desnos, M ;
Hagege, AA ;
Trent, RJ ;
Komajda, M ;
Fiszman, M ;
Schwartz, K .
CIRCULATION RESEARCH, 1997, 80 (03) :427-434
[4]   Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene [J].
Charron, P ;
Dubourg, O ;
Desnos, M ;
Bennaceur, M ;
Carrier, L ;
Camproux, AC ;
Isnard, R ;
Hagege, A ;
Langlard, JM ;
Bonne, G ;
Richard, P ;
Hainque, B ;
Bouhour, JB ;
Schwartz, K ;
Komajda, M .
CIRCULATION, 1998, 97 (22) :2230-2236
[5]   TRUNCATED ERYTHROPOIETIN RECEPTOR CAUSES DOMINANTLY INHERITED BENIGN HUMAN ERYTHROCYTOSIS [J].
DELACHAPELLE, A ;
TRASKELIN, AL ;
JUVONEN, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) :4495-4499
[6]   Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia [J].
Erdmann, J ;
ShimronAbarbanell, D ;
Rietschel, M ;
Albus, M ;
Maier, W ;
Korner, J ;
Bondy, B ;
Chen, K ;
Shih, JC ;
Knapp, M ;
Propping, P ;
Nothen, MM .
HUMAN GENETICS, 1996, 97 (05) :614-619
[7]   A molecular map of the interactions between titin and myosin-binding protein C - Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy [J].
Freiburg, A ;
Gautel, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 235 (1-2) :317-323
[8]  
Fung DC, 1999, HUM MUTAT, V14, P326, DOI 10.1002/(SICI)1098-1004(199910)14:4<326::AID-HUMU8>3.0.CO
[9]  
2-F
[10]   PHOSPHORYLATION SWITCHES SPECIFIC FOR THE CARDIAC ISOFORM OF MYOSIN BINDING PROTEIN-C - A MODULATOR OF CARDIAC CONTRACTION [J].
GAUTEL, M ;
ZUFFARDI, O ;
FREIBURG, A ;
LABEIT, S .
EMBO JOURNAL, 1995, 14 (09) :1952-1960